The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
Lidocaine and Prilocaine cream had annual sales of US $22.05 million in the United States (IQVIA MAT October 2024)
Demonstrates vision gains with extended treatment intervals in retinal vein occlusion
An investigational long-acting monoclonal antibody designed to protect infants from RSV disease during their first RSV season
Showing High Overall Response Rate (ORR) with durable responses and favorable safety profile in patients with heavily pretreated multiple myeloma
Aims to become India’s leading cancer testing company
Reaffirms Lupin’s commitment to sustainable resource management
Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR
The initiative will encourage and motivate emerging biotech startups, innovators and entrepreneurs
Subscribe To Our Newsletter & Stay Updated
